Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy. - Perrone S; Corbingi A; Vetro C; Palumbo FE; Minetto P; Riva C; Cicconi L; Vernarecci C; Lemoli RM; Pulsoni A; Guolo F (Annals of hematology, 2026)